Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	95.5	128.57	121.14	201.02	233.44
Cash & Short-Term Investments	95.5	128.57	121.14	201.02	233.44
Cash Growth	-25.72%	6.14%	-39.74%	-13.89%	149.65%
Other Current Assets	2.21	7.96	8.5	10.21	11.05
Total Current Assets	97.71	136.53	129.63	211.23	244.48
Net Property, Plant & Equipment	20.65	21	21.85	22.99	20.83
Other Intangible Assets	-	-	0.18	0.62	1.08
Other Long-Term Assets	-	-	-	-	0.4
Total Assets	118.36	157.53	151.66	234.83	266.78
Accounts Payable	41.65	7.65	10.57	4.02	7.13
Accrued Expenses	1.99	3.8	3.24	2.45	4.68
Current Portion of Leases	-	-	-	0.1	0.1
Other Current Liabilities	0.2	0.3	0.39	0.49	0.63
Total Current Liabilities	43.83	11.75	14.2	7.06	12.53
Long-Term Leases	-	-	-	0.04	0.14
Other Long-Term Liabilities	0.12	0.08	-	0.2	0.19
Total Long-Term Liabilities	0.12	0.08	-	0.23	0.33
Total Liabilities	43.95	11.83	14.2	7.3	12.87
Common Stock	0.05	0.05	0.04	0.04	0.04
Additional Paid-in Capital	570.44	550.77	518.2	511.05	461.18
Retained Earnings	-496.08	-405.11	-380.77	-283.55	-207.31
Shareholders' Equity	74.4	145.7	137.47	227.54	253.92
Total Liabilities & Equity	118.36	157.53	151.66	234.83	266.78
Total Debt	0	0	0	0.14	0.24
Net Cash (Debt)	95.5	128.57	121.14	200.88	233.2
Net Cash Growth	-25.72%	6.14%	-39.70%	-13.86%	150.18%
Net Cash Per Share	1.98	2.76	2.89	5.00	5.92
Book Value	74.4	145.7	137.47	227.54	253.92
Book Value Per Share	1.54	3.13	3.28	5.66	6.44
Tangible Book Value	74.4	145.7	137.29	226.92	252.84
Tangible Book Value Per Share	1.54	3.13	3.27	5.64	6.42

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q